AWRITER once comparedSino-foreign cultural ex- changes to a lengthybridge across the oceans of theworld.The Beijing CPAA Cultur- al Entertainment Company,esta- blished in the spring of this year,undoubtedly comes to m...AWRITER once comparedSino-foreign cultural ex- changes to a lengthybridge across the oceans of theworld.The Beijing CPAA Cultur- al Entertainment Company,esta- blished in the spring of this year,undoubtedly comes to many peo- ple’s minds when contemplatingthis remark.The Beijing CPAA Cultural En- tertainment Company is a subsidi- ary of the China Performing ArtsAgency,directly under the Ministryof Culture.It is a self-managed statefirm specializing in international ex-展开更多
Jushi Group Co.,Ltd.plans to optimize its existing products portfoliowith acquisitions to raise profit-making ability.The companyintends to directly purchase a 25% stake in P-D Jushi Intorglas fromP-D Glasseiden GmbH ...Jushi Group Co.,Ltd.plans to optimize its existing products portfoliowith acquisitions to raise profit-making ability.The companyintends to directly purchase a 25% stake in P-D Jushi Intorglas fromP-D Glasseiden GmbH Oschatz and buy a 25% stake in P-D JushiIntorglas from P-D Interglas Technologies AG through its subsidiaryJushi Hong Kong.P-D Jushi Intorglas gained 152% year-on-year in net profit toRMB7.26 million in Ql 2010.展开更多
On February 12th,Aluminum Corporation of China (Chinalco) signed an agreement to raise the stake in Rio Tinto Group of Australia.Chinalco will invest aggregate cash proceeds of US$19.5 billion in Rio Tinto Group,of wh...On February 12th,Aluminum Corporation of China (Chinalco) signed an agreement to raise the stake in Rio Tinto Group of Australia.Chinalco will invest aggregate cash proceeds of US$19.5 billion in Rio Tinto Group,of which totaling US＄12.3 billion in certain aluminum,copper and iron ore joint ventures,展开更多
Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of ...Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of March 3rd, 2009 in Tongjitang Chinese Medicines Company(NYSE: TCM) via its fully-owned subsidiary Fosun Pharmaceutical (Hong Kong)Limited for US$16.93 million. As a result, Fosun Pharm raised the stake to 15.94% forTCM’s total common shares.展开更多
文摘AWRITER once comparedSino-foreign cultural ex- changes to a lengthybridge across the oceans of theworld.The Beijing CPAA Cultur- al Entertainment Company,esta- blished in the spring of this year,undoubtedly comes to many peo- ple’s minds when contemplatingthis remark.The Beijing CPAA Cultural En- tertainment Company is a subsidi- ary of the China Performing ArtsAgency,directly under the Ministryof Culture.It is a self-managed statefirm specializing in international ex-
文摘Jushi Group Co.,Ltd.plans to optimize its existing products portfoliowith acquisitions to raise profit-making ability.The companyintends to directly purchase a 25% stake in P-D Jushi Intorglas fromP-D Glasseiden GmbH Oschatz and buy a 25% stake in P-D JushiIntorglas from P-D Interglas Technologies AG through its subsidiaryJushi Hong Kong.P-D Jushi Intorglas gained 152% year-on-year in net profit toRMB7.26 million in Ql 2010.
文摘On February 12th,Aluminum Corporation of China (Chinalco) signed an agreement to raise the stake in Rio Tinto Group of Australia.Chinalco will invest aggregate cash proceeds of US$19.5 billion in Rio Tinto Group,of which totaling US＄12.3 billion in certain aluminum,copper and iron ore joint ventures,
文摘Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of March 3rd, 2009 in Tongjitang Chinese Medicines Company(NYSE: TCM) via its fully-owned subsidiary Fosun Pharmaceutical (Hong Kong)Limited for US$16.93 million. As a result, Fosun Pharm raised the stake to 15.94% forTCM’s total common shares.
